Compare WT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WT | TXG |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2011 | 2019 |
| Metric | WT | TXG |
|---|---|---|
| Price | $13.88 | $19.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 14 |
| Target Price | $16.75 | ★ $17.18 |
| AVG Volume (30 Days) | ★ 2.2M | 2.2M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | ★ 127.27 | 76.97 |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $493,753,000.00 | $245,893,000.00 |
| Revenue This Year | $35.32 | N/A |
| Revenue Next Year | $8.08 | $7.26 |
| P/E Ratio | $19.43 | ★ N/A |
| Revenue Growth | 15.43 | ★ 68.06 |
| 52 Week Low | $7.47 | $6.78 |
| 52 Week High | $17.68 | $23.56 |
| Indicator | WT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 48.91 |
| Support Level | $13.07 | $11.62 |
| Resistance Level | $14.96 | $20.62 |
| Average True Range (ATR) | 0.61 | 1.22 |
| MACD | -0.13 | 0.09 |
| Stochastic Oscillator | 17.84 | 66.23 |
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).